ARS Pharmaceuticals (SPRY) Depreciation and Depletion (2020 - 2024)
ARS Pharmaceuticals (SPRY) reported Depreciation and Depletion of $29,000 for Q4 2024, up 141.7% from $12,000 a year earlier and up 38.1% from the prior quarter.
Powered by 
Analysis
ARS Pharmaceuticals (SPRY) Depreciation and Depletion (2020 - 2024) Analysis & Trends
For FY2024, ARS Pharmaceuticals posted Depreciation and Depletion of $79,000, up 8.2% from FY2023.
- Depreciation and Depletion has a four-year compound annual growth rate of -40.7% (FY2020 to FY2024).
- By year, Depreciation and Depletion came in at $73,000 in FY2023 (+114.7%), $34,000 in FY2022 (-95.8%), $800,000 in FY2021 (+25.6%) and $637,000 in FY2020.
- The Q4 2024 figure ranks as the highest quarterly Depreciation and Depletion since Q1 2022.
- Year over year, Depreciation and Depletion gained in two of the last seven quarters, with growth averaging 30.3%.
- The high point for year-over-year Depreciation and Depletion in five years was Q3 2023 (growth of 200.0%); the low point was Q3 2022 (a decline of 96.5%).
- Per Business Quant data, the three quarters before Q4 2024 came in at $21,000 (Q3 2024), $18,000 (Q2 2024) and $11,000 (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 192.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 726.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 132.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | ARS Pharmaceuticals | 357.89 Mn | 219.49 Mn | 27.61 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 29,000.00 |
| Sep 30, 2024 | 21,000.00 |
| Jun 30, 2024 | 18,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 12,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | 20,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Jun 30, 2022 | -37,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 204,000.00 |
| Sep 30, 2021 | 201,000.00 |
| Jun 30, 2021 | 209,000.00 |
| Mar 31, 2021 | 186,000.00 |
| Dec 31, 2020 | 189,000.00 |
| Sep 30, 2020 | 171,000.00 |
| Jun 30, 2020 | 138,000.00 |
| Mar 31, 2020 | 139,000.00 |
API Access
ARS Pharmaceuticals Depreciation and Depletion API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=SPRY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-depletion", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();